Taiwan · Delayed Price · Currency is TWD Nang Kuang Pharmaceutical Statistics
Total Valuation
TPE:1752 has a market cap or net worth of TWD 3.42 billion. The enterprise value is 3.80 billion.
| Market Cap | 3.42B |
| Enterprise Value | 3.80B |
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
TPE:1752 has 100.99 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 100.99M |
| Shares Outstanding | 100.99M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 24.53% |
| Owned by Institutions (%) | 1.08% |
| Float | 42.55M |
Valuation Ratios
The trailing PE ratio is 16.73.
| PE Ratio | 16.73 |
| Forward PE | n/a |
| PS Ratio | 1.62 |
| PB Ratio | 1.45 |
| P/TBV Ratio | 1.46 |
| P/FCF Ratio | 82.19 |
| P/OCF Ratio | 9.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.54, with an EV/FCF ratio of 91.14.
| EV / Earnings | 18.52 |
| EV / Sales | 1.80 |
| EV / EBITDA | 8.54 |
| EV / EBIT | 14.42 |
| EV / FCF | 91.14 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.22 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.56 |
| Debt / FCF | 16.69 |
| Interest Coverage | 30.41 |
Financial Efficiency
Return on equity (ROE) is 8.69% and return on invested capital (ROIC) is 8.75%.
| Return on Equity (ROE) | 8.69% |
| Return on Assets (ROA) | 4.26% |
| Return on Invested Capital (ROIC) | 8.75% |
| Return on Capital Employed (ROCE) | 10.02% |
| Weighted Average Cost of Capital (WACC) | 4.39% |
| Revenue Per Employee | 3.83M |
| Profits Per Employee | 371,293 |
| Employee Count | 552 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, TPE:1752 has paid 39.28 million in taxes.
| Income Tax | 39.28M |
| Effective Tax Rate | 16.15% |
Stock Price Statistics
The stock price has decreased by -7.38% in the last 52 weeks. The beta is 0.15, so TPE:1752's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -7.38% |
| 50-Day Moving Average | 35.73 |
| 200-Day Moving Average | 36.75 |
| Relative Strength Index (RSI) | 31.67 |
| Average Volume (20 Days) | 88,518 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1752 had revenue of TWD 2.11 billion and earned 204.95 million in profits. Earnings per share was 2.03.
| Revenue | 2.11B |
| Gross Profit | 736.53M |
| Operating Income | 263.22M |
| Pretax Income | 243.22M |
| Net Income | 204.95M |
| EBITDA | 443.99M |
| EBIT | 263.22M |
| Earnings Per Share (EPS) | 2.03 |
Balance Sheet
The company has 327.26 million in cash and 695.00 million in debt, with a net cash position of -367.74 million or -3.64 per share.
| Cash & Cash Equivalents | 327.26M |
| Total Debt | 695.00M |
| Net Cash | -367.74M |
| Net Cash Per Share | -3.64 |
| Equity (Book Value) | 2.36B |
| Book Value Per Share | 23.32 |
| Working Capital | 272.83M |
Cash Flow
In the last 12 months, operating cash flow was 358.82 million and capital expenditures -317.16 million, giving a free cash flow of 41.65 million.
| Operating Cash Flow | 358.82M |
| Capital Expenditures | -317.16M |
| Depreciation & Amortization | 182.39M |
| Net Borrowing | 17.46M |
| Free Cash Flow | 41.65M |
| FCF Per Share | 0.41 |
Margins
Gross margin is 34.87%, with operating and profit margins of 12.46% and 9.70%.
| Gross Margin | 34.87% |
| Operating Margin | 12.46% |
| Pretax Margin | 11.51% |
| Profit Margin | 9.70% |
| EBITDA Margin | 21.02% |
| EBIT Margin | 12.46% |
| FCF Margin | 1.97% |
Dividends & Yields
This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 4.72%.
| Dividend Per Share | 1.60 |
| Dividend Yield | 4.72% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 78.84% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 4.70% |
| Earnings Yield | 5.99% |
| FCF Yield | 1.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2014. It was a forward split with a ratio of 1.07.
| Last Split Date | Sep 23, 2014 |
| Split Type | Forward |
| Split Ratio | 1.07 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |